Immunoneutralization of growth differentiation factor 9 reveals it partially accounts for mouse oocyte mitogenic activity

被引:74
作者
Gilchrist, RB [1 ]
Ritter, LJ
Cranfield, M
Jeffery, LA
Amato, F
Scott, SJ
Myllymaa, S
Kaivo-Oja, N
Lankinen, H
Mottershead, DG
Groome, NP
Ritvos, O
机构
[1] Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Res Ctr Reprod Hlth, Woodville, SA 5011, Australia
[2] Oxford Brookes Univ, Sch Biol & Mol Sci, Oxford OX3 0BP, England
[3] Univ Helsinki, Biomedicum, Programme Dev & Reprod Biol, FIN-00014 Helsinki, Finland
[4] Univ Helsinki, Dept Bacteriol & Immunol, Peptide & Prot Lab, Dept Virol, FIN-00014 Helsinki, Finland
关键词
follicle; granulosa cells; growth factors; ovary; ovum;
D O I
10.1095/biolreprod.104.028852
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Paracrine factors secreted by oocytes play a pivotal role in promoting early ovarian follicle growth and in defining a morphogenic gradient in antral follicles, yet the exact identities of these oocyte factors remain unknown. This study was conducted to determine the extent to which the mitogenic activity of mouse oocytes can be attributed to growth differentiation factor 9 (GDF9). To do this, specific anti-human GDF9 monoclonal antibodies were generated. Based on epitope mapping and bioassays, a GDF9 neutralizing antibody, mAb-GDF9-53, was characterized with very low cross-reactivity with related transforming growth factor(TGF)beta superfamily members, including BMP15 (also called GDF9B). Pep-SPOT epitope mapping showed that mAb-GDF9-53 recognizes a short 4-aa sequence, and three-dimensional peptide modeling suggested that this binding motif lies at the C-terminal fingertip of mGDF9. As predicted by sequence alignments and modeling, the antibody detected recombinant GDF9, but not BMP15 in a Western blot and GDF9 protein in oocyte extract and oocyte-conditioned medium. In a mouse mural granulosa cell (MGC) bioassay, mAb-GDF9-53 completely abolished the mitogenic effects of GDF9, but had no effect on TGFbeta1 or activin A-stimulated MGC proliferation. An unrelated IgG at the same dose had no effect on GDF9 activity. This GDF9 neutralizing antibody was then tested in an established oocyte-secreted mitogen bioassay, where denuded oocytes cocultured with granulosa cells promote cell proliferation in a dose-dependent manner. The mAb-GDF9-53 dose dependently (0-160 mug/ml) decreased the mitogenic activity of oocytes but only by similar to45% at the maximum dose of mAb. Just 5 mug/ml of mAb-GDF9-53 neutralized 90% of recombinant mGDF9 mitogenic activity, but only 15% of oocyte activity. Unlike mAb-GDF9-53, a TGFbeta pan-specific neutralizing antibody did not affect the mitogenic capacity of the oocyte, but completely neutralized TGFbeta1-induced DNA synthesis. This study has characterized a specific GDF9 neutralizing antibody. Our data provide the first direct evidence that the endogenous GDF9 protein is an important oocyte-secreted mitogen, but also show that GDF9 accounts for only part of total oocyte bioactivity.
引用
收藏
页码:732 / 739
页数:8
相关论文
共 43 条
[1]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[2]  
Bates PA, 1999, PROTEINS, P47
[3]   FSH-INDUCED EXPANSION OF THE MOUSE CUMULUS-OOPHORUS INVITRO IS DEPENDENT UPON A SPECIFIC FACTOR(S) SECRETED BY THE OOCYTE [J].
BUCCIONE, R ;
VANDERHYDEN, BC ;
CARON, PJ ;
EPPIG, JJ .
DEVELOPMENTAL BIOLOGY, 1990, 138 (01) :16-25
[4]   Growth differentiation factor-9 is required during early ovarian folliculogenesis [J].
Dong, JW ;
Albertini, DF ;
Nishimori, K ;
Kumar, TR ;
Lu, NF ;
Matzuk, MM .
NATURE, 1996, 383 (6600) :531-535
[5]   Paracrine actions of growth differentiation factor-9 in the mammalian ovary [J].
Elvin, JA ;
Clark, AT ;
Wang, P ;
Wolfman, NM ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (06) :1035-1048
[6]   Oocyte control of ovarian follicular development and function in mammals [J].
Eppig, JJ .
REPRODUCTION, 2001, 122 (06) :829-838
[7]   Murine oocytes suppress expression of luteinizing hormone receptor messenger ribonucleic acid by granulosa cells [J].
Eppig, JJ ;
Wigglesworth, K ;
Pendola, F ;
Hirao, Y .
BIOLOGY OF REPRODUCTION, 1997, 56 (04) :976-984
[8]   Expression of growth differentiation factor-9 messenger ribonucleic acid in ovarian and nonovarian rodent and human tissues [J].
Fitzpatrick, SL ;
Sindoni, DM ;
Shughrue, PJ ;
Lane, MV ;
Merchenthaler, IJ ;
Frail, DE .
ENDOCRINOLOGY, 1998, 139 (05) :2571-2578
[9]   Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner [J].
Galloway, SM ;
McNatty, KP ;
Cambridge, LM ;
Laitinen, MPE ;
Juengel, JL ;
Jokiranta, TS ;
McLaren, RJ ;
Luiro, K ;
Dodds, KG ;
Montgomery, GW ;
Beattie, AE ;
Davis, GH ;
Ritvos, O .
NATURE GENETICS, 2000, 25 (03) :279-283
[10]   Comparison of oocyte factors and transforming growth factor-β in the regulation of DNA synthesis in bovine granulosa cells [J].
Gilchrist, RB ;
Morrissey, MP ;
Ritter, LJ ;
Armstrong, DT .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 201 (1-2) :87-95